Prevalence, Contribution to Disease Burden and Management of Comorbid Depression and Anxiety in Chronic Obstructive Pulmonary Disease: A Narrative Review

References

• Schwartz AG, Cote ML. Epidemiology of lung cancer. Adv Exp Med Biol. 2016;893:21–41. doi:10.1007/978-3-319-24223-1_2.
   PubMed Web of Science ®Google Scholar
• Schuler M, Wittmann M, Faller H. The interrelations among aspects of dyspnea and symptoms of depression in COPD patients – a network analysis. J Affect Disord. 2018;240:33–40. doi:10.1016/j.jad.2018.07.021.
   PubMed Web of Science ®Google Scholar
• Omachi TA, Katz PP, Yelin EH, et al. Depression and health-related quality of life in chronic obstructive pulmonary disease. Am J Med. 2009;122:778.e9–778.e15. doi:10.1016/j.amjmed.2009.01.036.
   Web of Science ®Google Scholar
• Yohannes AM, Chen W, Moga AM, et al. Cognitive impairment in chronic obstructive pulmonary disease and chronic heart failure: a systematic review and meta-analysis of observational studies. J Am Med Dir Assoc. 2017;18:451.e1–451.e11. doi:10.1016/j.jamda.2017.01.014.
   Web of Science ®Google Scholar
• Jones C, Hacker D, Cormac I, et al. Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia. Cochrane Database Syst Rev. 2012:CD008712.
   PubMed Web of Science ®Google Scholar
• Kapczinski F, Lima MS, Souza JS, et al. Antidepressants for generalized anxiety disorder. Cochrane Database Syst Rev. 2003;CD003592.
   PubMedGoogle Scholar
• American Psychiatric Association DSM-5 Task Force. Diagnostic and statistical manual of mental disorders: DSM-5^TM. 5th ed. Arlington (VA): American Psychiatric Publishing, Inc.; 2013.
   Google Scholar
• Chen R, Guan L, Wu W, et al. The Chinese version of the Severe Respiratory Insufficiency questionnaire for patients with chronic hypercapnic chronic obstructive pulmonary disease receiving non-invasive positive pressure ventilation. BMJ Open. 2017;7:e017712. doi:10.1136/bmjopen-2017-017712.
   PubMed Web of Science ®Google Scholar
• Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606–613. doi:10.1046/j.1525-1497.2001.016009606.x.
   PubMed Web of Science ®Google Scholar
• Schuler M, Strohmayer M, Muhlig S, et al. Assessment of depression before and after inpatient rehabilitation in COPD patients: psychometric properties of the German version of the Patient Health Questionnaire (PHQ-9/PHQ-2). J Affect Disord. 2018;232:268–275. doi:10.1016/j.jad.2018.02.037.
   PubMed Web of Science ®Google Scholar
• Phan T, Carter O, Adams C, et al. Discriminant validity of the Hospital Anxiety and Depression Scale, Beck Depression Inventory (II) and Beck Anxiety Inventory to confirmed clinical diagnosis of depression and anxiety in patients with chronic obstructive pulmonary disease. Chron Respir Dis. 2016;13:220–228. doi:10.1177/1479972316634604.
   PubMed Web of Science ®Google Scholar
• Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–370. doi:10.1111/j.1600-0447.1983.tb09716.x.
   PubMed Web of Science ®Google Scholar
• Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–571. doi:10.1001/archpsyc.1961.01710120031004.
   PubMed Web of Science ®Google Scholar
• Beck AT, Epstein N, Brown G, et al. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56:893–897. doi:10.1037//0022-006x.56.6.893.
   PubMed Web of Science ®Google Scholar
• Pierobon A, Ranzini L, Torlaschi V, et al. Screening for neuropsychological impairment in COPD patients undergoing rehabilitation. PLoS One. 2018;13:e0199736. doi:10.1371/journal.pone.0199736.
   PubMed Web of Science ®Google Scholar
• Willgoss TG, Goldbart J, Fatoye F, et al. The development and validation of the anxiety inventory for respiratory disease. Chest. 2013;144:1587–1596. doi:10.1378/chest.13-0168.
   PubMed Web of Science ®Google Scholar
• Baker AM, Holbrook JT, Yohannes AM, et al. Test performance characteristics of the AIR, GAD-7 and HADS-Anxiety Screening Questionnaires for anxiety in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2018. DOI:10.1513/AnnalsATS.201708-631OC.
   Web of Science ®Google Scholar
• Spitzer RL, Kroenke K, Williams JBW, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092–1097. doi:10.1001/archinte.166.10.1092.
   PubMed Web of Science ®Google Scholar
• Jones PW, Quirk FH, Baveystock CM. The St George’s Respiratory Questionnaire. Respir Med. 1991;85:25–27. doi:10.1016/S0954-6111(06)80166-6.
   PubMed Web of Science ®Google Scholar
• Slok AHM, Bemelmans TCH, Kotz D, et al. The Assessment of Burden of COPD (ABC) Scale: a reliable and valid questionnaire. COPD 2016;13:431–438. doi:10.3109/15412555.2015.1118025.
   PubMedGoogle Scholar
• Bock K, Bendstrup E, Hilberg O, et al. Screening tools for evaluation of depression in Chronic Obstructive Pulmonary Disease (COPD). A systematic review. Eur Clin Respir J. 2017;4(1):1332931. doi:10.1080/20018525.2017.1332931.
   PubMed Web of Science ®Google Scholar
• Zhang MWB, Ho RCM, Cheung MWL, et al. Prevalence of depressive symptoms in patients with chronic obstructive pulmonary disease: a systematic review, meta-analysis and meta-regression. Gen Hosp Psychiatry. 2011;33:217–223. doi:10.1016/j.genhosppsych.2011.03.009.
   PubMed Web of Science ®Google Scholar
• Aghanwa HS, Erhabor GE. Specific psychiatric morbidity among patients with chronic obstructive pulmonary disease in a Nigerian general hospital. J Psychosom Res. 2001;50:179–183. doi:10.1016/S0022-3999(00)00206-3.
   PubMed Web of Science ®Google Scholar
• Engstrom CP, Persson LO, Larsson S, et al. Functional status and well being in chronic obstructive pulmonary disease with regard to clinical parameters and smoking: a descriptive and comparative study. Thorax. 1996;51:825–830. doi:10.1136/thx.51.8.825.
   PubMed Web of Science ®Google Scholar
• Hanania NA, Mullerova H, Locantore NW, et al. Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med. 2011;183:604–611. doi:10.1164/rccm.201003-0472OC.
   PubMed Web of Science ®Google Scholar
• Ng T-P, Niti M, Fones C, et al. Co-morbid association of depression and COPD: a population-based study. Respir Med. 2009;103:895–901. doi:10.1016/j.rmed.2008.12.010.
   PubMed Web of Science ®Google Scholar
• Schneider C, Jick SS, Bothner U, et al. COPD and the risk of depression. Chest. 2010;137:341–347. doi:10.1378/chest.09-0614.
   PubMed Web of Science ®Google Scholar
• van Manen JG, Bindels PJE, Dekker FW, et al. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax. 2002;57:412–416. doi:10.1136/thorax.57.5.412.
   PubMed Web of Science ®Google Scholar
• Yohannes AM, Roomi J, Baldwin RC, et al. Depression in elderly outpatients with disabling chronic obstructive pulmonary disease. Age Ageing. 1998;27:155–160. doi:10.1093/ageing/27.2.155.
   PubMed Web of Science ®Google Scholar
• Willgoss TG, Yohannes AM. Anxiety disorders in patients with COPD: a systematic review. Respir Care. 2013;58:858–866. doi:10.4187/respcare.01862.
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Price D, Rabe KF, et al. Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015;10:549–564.
   PubMed Web of Science ®Google Scholar
• Pothirat C, Chaiwong W, Phetsuk N, et al. Major affective disorders in chronic obstructive pulmonary disease compared with other chronic respiratory diseases. Int J Chron Obstruct Pulmon Dis. 2015;10:1583–1590.
   PubMed Web of Science ®Google Scholar
• Bania EG, Daniil Z, Hatzoglou C, et al. COPD characteristics and socioeconomic burden in Hellenic correctional institutions. Int J Chron Obstruct Pulmon Dis. 2016;11:341–349.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gutierrez MV, Guerrero Velazquez J, Morales Garcia C, et al. Predictive model for anxiety and depression in Spanish patients with stable chronic obstructive pulmonary disease. Arch Bronconeumol. 2016;52:151–157.
   PubMed Web of Science ®Google Scholar
• Biswas D, Mukherjee S, Chakroborty R, et al. Occurrence of anxiety and depression among stable COPD patients and its impact on functional capability. J Clin Diagn Res. 2017;11:OC24–OC27.
   PubMed Web of Science ®Google Scholar
• Thapa N, Maharjan M, Shrestha TM, et al. Anxiety and depression among patients with chronic obstructive pulmonary disease and general population in rural Nepal. BMC Psychiatry. 2017;17:397. doi:10.1186/s12888-017-1550-5.
   PubMed Web of Science ®Google Scholar
• Raherison C, Ouaalaya E-H, Bernady A, et al. Comorbidities and COPD severity in a clinic-based cohort. BMC Pulm Med. 2018;18:117. doi:10.1186/s12890-018-0684-7.
   PubMed Web of Science ®Google Scholar
• Stallberg B, Janson C, Larsson K, et al. Real-world retrospective cohort study ARCTIC shows burden of comorbidities in Swedish COPD versus non-COPD patients. NPJ Prim Care Respir Med. 2018;28:33.
   PubMed Web of Science ®Google Scholar
• Xiao T, Qiu H, Chen Y, et al. Prevalence of anxiety and depression symptoms and their associated factors in mild COPD patients from community settings, Shanghai, China: a cross-sectional study. BMC Psychiatry. 2018;18:89. doi:10.1186/s12888-018-1671-5.
   PubMed Web of Science ®Google Scholar
• Silva Junior JLR, Conde MB, de Sousa Correa K, et al. COPD Assessment Test (CAT) score as a predictor of major depression among subjects with chronic obstructive pulmonary disease and mild hypoxemia: a case-control study. BMC Pulm Med. 2014;14:186.
   PubMed Web of Science ®Google Scholar
• Kamour A, David M, Kanotra S. Prevalence and comorbidities of chronic obstructive pulmonary disease among adults in Kentucky across gender and area development districts, 2011. Chronic Obstr Pulm Dis. 2015;2:296–312. doi:10.15326/jcopdf.2.4.2015.0138.
   PubMed Web of Science ®Google Scholar
• Albrecht JS, Huang T-Y, Park Y, et al. New episodes of depression among Medicare beneficiaries with chronic obstructive pulmonary disease. Int J Geriatr Psychiatry. 2016;31:441–449. doi:10.1002/gps.4348.
   PubMed Web of Science ®Google Scholar
• Garin N, Koyanagi A, Chatterji S, et al. Global multimorbidity patterns: a cross-sectional, population-based, multi-country study. J Gerontol A Biol Sci Med Sci. 2016;71:205–214. doi:10.1093/gerona/glv128.
   PubMed Web of Science ®Google Scholar
• Himani G, Badini A, Nanji K. Depression and its associated factors among patients with chronic obstructive pulmonary disease in Karachi. Pakistan Cureus. 2018;10:e2930.
   PubMed Web of Science ®Google Scholar
• Kayhan F, Ilik F, Karamanli H, et al. Major depression in long-term oxygen therapy dependent chronic obstructive pulmonary disease. Perspect Psychiatr Care. 2018;54:6–10. doi:10.1111/ppc.12169.
   PubMed Web of Science ®Google Scholar
• Lee J-H, Park MA, Park MJ, et al. Clinical characteristics and related risk factors of depression in patients with early COPD. COPD. 2018;13:1583–1590. doi:10.2147/COPD.S157165.
   Google Scholar
• Zareifopoulos N, Bellou A, Spiropoulou A, et al. Prevalence of comorbid chronic obstructive pulmonary disease in individuals suffering from schizophrenia and bipolar disorder: a systematic review. COPD J Chronic Obstr Pulm Dis. [Internet]. 2018;15:612–620. Available from: doi:10.1080/15412555.2019.1572730.
   PubMed Web of Science ®Google Scholar
• Martinez Rivera C, Costan Galicia J, Alcazar Navarrete B, et al. Factors associated with depression in COPD: a multicenter study. Lung. 2016;194:335–343. doi:10.1007/s00408-016-9862-7.
   PubMed Web of Science ®Google Scholar
• Lee SH, Hwang ED, Lim JE, et al. The risk factors and characteristics of COPD among nonsmokers in Korea: an analysis of KNHANES IV and V. Lung. 2016;194:353–361. doi:10.1007/s00408-016-9871-6.
   PubMed Web of Science ®Google Scholar
• Pascal OI, Trofor AC, Lotrean LM, et al. Depression, anxiety and panic disorders in chronic obstructive pulmonary disease patients: correlations with tobacco use, disease severity and quality of life. Tob Induc Dis. 2017;15:23.
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Molina J, Quintano JA, et al. Factors associated with depression and severe depression in patients with COPD. Respir Med. 2014;108:1615–1625. doi:10.1016/j.rmed.2014.08.010.
   PubMed Web of Science ®Google Scholar
• Spiropoulou A, Zareifopoulos N, Bellou A, et al. Review of the association between periodontitis and chronic obstructive pulmonary disease in smokers. Monaldi Arch Chest Dis. [Internet]. 2019;89. Available from: https://monaldi-archives.org/index.php/macd/article/view/1018
   PubMed Web of Science ®Google Scholar
• Rybka J, Korte SM, Czajkowska-Malinowska M, et al. The links between chronic obstructive pulmonary disease and comorbid depressive symptoms: role of IL-2 and IFN-gamma. Clin Exp Med. 2016;16:493–502. doi:10.1007/s10238-015-0391-0.
   PubMed Web of Science ®Google Scholar
• Janssen DJA, Mullerova H, Agusti A, et al. Persistent systemic inflammation and symptoms of depression among patients with COPD in the ECLIPSE cohort. Respir Med. 2014;108:1647–1654. doi:10.1016/j.rmed.2014.07.013.
   PubMed Web of Science ®Google Scholar
• Sundh J, Johansson G, Larsson K, et al. Comorbidity and health-related quality of life in patients with severe chronic obstructive pulmonary disease attending Swedish secondary care units. Int J Chron Obstruct Pulmon Dis. 2015;10:173–183.
   PubMed Web of Science ®Google Scholar
• McGarvey L, Lee AJ, Roberts J, et al. Characterisation of the frequent exacerbator phenotype in COPD patients in a large UK primary care population. Respir Med. 2015;109:228–237. doi:10.1016/j.rmed.2014.12.006.
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Barrecheguren M, Román-Rodríguez M. Frequency and characteristics of different clinical phenotypes of chronic obstructive pulmonary disease. Int J Tuberc Lung Dis. 2015;19:992–998.
   PubMed Web of Science ®Google Scholar
• Kania A, Krenke R, Kuziemski K, et al. Distribution and characteristics of COPD phenotypes – results from the Polish sub-cohort of the POPE study. COPD. 2018;13:1613–1621.
   Google Scholar
• Tse HN, Tseng CZS, Wong KY, et al. Frequent exacerbator: the phenotype at risk of depressive symptoms in geriatric COPD patients. Lung. 2016;194:665–673. doi:10.1007/s00408-016-9887-y.
   PubMed Web of Science ®Google Scholar
• Papaioannou AI, Tsikrika S, Bartziokas K, et al. Collateral damage: depressive symptoms in the partners of COPD patients. Lung. 2014;192:519–524. doi:10.1007/s00408-014-9595-4.
   PubMed Web of Science ®Google Scholar
• Jacome C, Figueiredo D, Gabriel R, et al. Predicting anxiety and depression among family carers of people with chronic obstructive pulmonary disease. Int Psychogeriatr. 2014;26:1191–1199. doi:10.1017/S1041610214000337.
   PubMed Web of Science ®Google Scholar
• Mi E, Mi E, Ewing G, et al. Associations between the psychological health of patients and carers in advanced COPD. COPD. 2017;12:2813–2821. doi:10.2147/COPD.S139188.
   Google Scholar
• Miravitlles M, Pena-Longobardo LM, Oliva-Moreno J, et al. Caregivers’ burden in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2015;10:347–356.
   PubMed Web of Science ®Google Scholar
• Frei A, Muggensturm P, Putcha N, et al. Five comorbidities reflected the health status in patients with chronic obstructive pulmonary disease: the newly developed COMCOLD index. J Clin Epidemiol. 2014;67:904–911. doi:10.1016/j.jclinepi.2014.03.005.
   PubMed Web of Science ®Google Scholar
• Jang SM, Kim KU, Na HJ, et al. Depression is a major determinant of both disease-specific and generic health-related quality of life in people with severe COPD. Chron Respir Dis. 2018:1479972318775422. doi:10.1177/1479972318775422.
   Web of Science ®Google Scholar
• Miravitlles M, Cantoni J, Naberan K. Factors associated with a low level of physical activity in patients with chronic obstructive pulmonary disease. Lung. 2014;192:259–265. doi:10.1007/s00408-014-9557-x.
   PubMed Web of Science ®Google Scholar
• Duenas-Espin I, Demeyer H, Gimeno-Santos E, et al. Depression symptoms reduce physical activity in COPD patients: a prospective multicenter study. Int J Chron Obstruct Pulmon Dis. 2016;11:1287–1295.
   PubMed Web of Science ®Google Scholar
• Tottenborg SS, Thomsen RW, Johnsen SP, et al. Determinants of smoking cessation in patients with COPD treated in the outpatient setting. Chest. 2016;150:554–562. doi:10.1016/j.chest.2016.05.020.
   PubMed Web of Science ®Google Scholar
• Uchmanowicz I, Jankowska-Polanska B, Motowidlo U, et al. Assessment of illness acceptance by patients with COPD and the prevalence of depression and anxiety in COPD. Int J Chron Obstruct Pulmon Dis. [Internet]. 2016;11:963–970. Available from: https://www.ncbi.nlm.nih.gov/pubmed/27274217
   PubMed Web of Science ®Google Scholar
• Chung JH, Han CH, Park SC, et al. Suicidal ideation and suicide attempts in chronic obstructive pulmonary disease: the Korea National Health and Nutrition Examination Survey (KNHANES IV, V) from 2007-2012. NPJ Prim Care Respir Med. 2014;24:14094.
   PubMed Web of Science ®Google Scholar
• Fleehart S, Fan VS, Nguyen HQ, et al. Prevalence and correlates of suicide ideation in patients with COPD: a mixed methods study. Int J Chron Obstruct Pulmon Dis. 2015;10:1321–1329.
   PubMedGoogle Scholar
• Lou P, Chen P, Zhang P, et al. Effects of smoking, depression, and anxiety on mortality in COPD patients: a prospective study. Respir Care. 2014;59:54–61. doi:10.4187/respcare.02487.
   PubMed Web of Science ®Google Scholar
• Qian J, Simoni-Wastila L, Rattinger GB, et al. Associations of depression diagnosis and antidepressant treatment with mortality among young and disabled Medicare beneficiaries with COPD. Gen Hosp Psychiatry. 2013;35:612–618. doi:10.1016/j.genhosppsych.2013.06.005.
   PubMed Web of Science ®Google Scholar
• Mullerova H, Shukla A, Hawkins A, et al. Risk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort study. BMJ Open. 2014;4:e006171. doi:10.1136/bmjopen-2014-006171.
   PubMed Web of Science ®Google Scholar
• Yohannes AM, Mulerova H, Lavoie K, et al. The association of depressive symptoms with rates of acute exacerbations in patients with COPD: results from a 3-year longitudinal follow-up of the ECLIPSE cohort. J Am Med Dir Assoc. 2017;18:955–959.e6. doi:10.1016/j.jamda.2017.05.024.
   PubMed Web of Science ®Google Scholar
• Montserrat-Capdevila J, Godoy P, Marsal JR, et al. Mental disorders in chronic obstructive pulmonary diseases. Perspect Psychiatr Care. 2018;54:398–404. doi:10.1111/ppc.12274.
   PubMed Web of Science ®Google Scholar
• Singh G, Zhang W, Kuo Y-F, et al. Association of psychological disorders with 30-day readmission rates in patients with COPD. Chest. 2016;149:905–915. doi:10.1378/chest.15-0449.
   PubMed Web of Science ®Google Scholar
• Iyer AS, Bhatt SP, Garner JJ, et al. Depression is associated with readmission for acute exacerbation of chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2016;13:197–203.
   PubMed Web of Science ®Google Scholar
• Albrecht JS, Park Y, Hur P, et al. Adherence to maintenance medications among older adults with chronic obstructive pulmonary disease. The role of depression. Ann ATS. 2016;13:1497–1504. doi:10.1513/AnnalsATS.201602-136OC.
   Google Scholar
• Albrecht JS, Khokhar B, Huang T-Y, et al. Adherence and healthcare utilization among older adults with COPD and depression. Respir Med. 2017;129:53–58. doi:10.1016/j.rmed.2017.06.002.
   PubMed Web of Science ®Google Scholar
• Dodd JW, Hogg L, Nolan J, et al. The COPD assessment test (CAT): response to pulmonary rehabilitation. A multicentre, prospective study. Thorax. [Internet]. 2011;66:425–429. Available from: http://thorax.bmj.com/content/66/5/425.abstract doi:10.1136/thx.2010.156372.
   PubMed Web of Science ®Google Scholar
• He Y, Zheng Y, Xu C, et al. Sertraline hydrochloride treatment for patients with stable chronic obstructive pulmonary disease complicated with depression: a randomized controlled trial. Clin Respir J. 2016;10:318–325. doi:10.1111/crj.12219.
   PubMed Web of Science ®Google Scholar
• Hyun MK, Lee NR, Jang EJ, et al. Effect of inhaled drugs on anxiety and depression in patients with chronic obstructive pulmonary disease: a prospective observational study. Int J Chron Obstruct Pulmon Dis. 2016;11:747–754.
   PubMed Web of Science ®Google Scholar
• Zareifopoulos N, Panayiotakopoulos G. Neuropsychiatric effects of antimicrobial agents. Clin Drug Investig. 2017;37:423–437.
   PubMed Web of Science ®Google Scholar
• Kotz D, Viechtbauer W, Simpson CR, et al. Cardiovascular and neuropsychiatric risks of varenicline and bupropion in smokers with chronic obstructive pulmonary disease. Thorax. 2017;72:905–911. doi:10.1136/thoraxjnl-2017-210067.
   PubMed Web of Science ®Google Scholar
• Doyle C, Bhar S, Fearn M, et al. The impact of telephone-delivered cognitive behaviour therapy and befriending on mood disorders in people with chronic obstructive pulmonary disease: a randomized controlled trial. Br J Health Psychol. 2017;22:542–556.
   PubMed Web of Science ®Google Scholar
• Alexopoulos GS, Sirey JA, Banerjee S, et al. Two behavioral interventions for patients with major depression and severe COPD. Am J Geriatr Psychiatry. 2016;24:964–974. doi:10.1016/j.jagp.2016.07.014.
   PubMed Web of Science ®Google Scholar
• Alexopoulos GS, Sirey JA, Banerjee S, et al. Two interventions for patients with major depression and severe chronic obstructive pulmonary disease: impact on dyspnea-related disability. Am J Geriatr Psychiatry. 2018;26:162–171. doi:10.1016/j.jagp.2017.10.002.
   PubMed Web of Science ®Google Scholar
• Usmani ZA, Carson KV, Heslop K, et al. Psychological therapies for the treatment of anxiety disorders in chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2017;3:CD010673.
   PubMedGoogle Scholar
• de Godoy DV, de Godoy RF. A randomized controlled trial of the effect of psychotherapy on anxiety and depression in chronic obstructive pulmonary disease. Arch Phys Med Rehabil. 2003;84:1154–1157. doi:10.1016/S0003-9993(03)00239-9.
   PubMed Web of Science ®Google Scholar
• Hynninen MJ, Bjerke N, Pallesen S, et al. A randomized controlled trial of cognitive behavioral therapy for anxiety and depression in COPD. Respir Med. 2010;104:986–994. doi:10.1016/j.rmed.2010.02.020.
   PubMed Web of Science ®Google Scholar
• Kunik ME, Veazey C, Cully JA, et al. COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: a randomized controlled trial. Psychol Med. 2008;38:385–396. doi:10.1017/S0033291707001687.
   PubMed Web of Science ®Google Scholar
• Deb A, Sambamoorthi U. Depression treatment patterns among adults with chronic obstructive pulmonary disease and depression. Curr Med Res Opin. 2017;33:201–208.
   PubMed Web of Science ®Google Scholar
• Yohannes AM. Management of anxiety and depression in patients with COPD. Expert Rev Respir Med. 2008;2:337–347. doi:10.1586/17476348.2.3.337.
   PubMedGoogle Scholar